Open access
Oct 2026
Factors associated with pharmacoresistance in patients with epilepsy: analysis of clinical predictors
The findings reinforce that patients with focal/structural epilepsy, abnormal complementary tests, higher seizure frequency, and neuropsychiatric comorbidities should be recognized early as a higherrisk group.
Sabryna Alves Dias, Marlon Cantillo da Luz, P. Basso et al.
· ANPAbstract_CBN26 · 0 citations